Browsing by Author "Böke Ö."
Now showing items 1-6 of 6
-
-1438 G/A 5-HT2A receptor gene polymorphisms in patients with schizophrenia
Özgür Güneş S.; Böke Ö.; Kara N.; Şahin A.R.; Bağci H.; Başar Y. (2006)Objective: Serotonin (5-HT) plays a key role in central nervous system. Serotonergic dysfunction may be involved in the pathogenesis of schizophrenia. 5-HT2A receptor gene maps to 13q14-21. This study aimed to investigate ... -
Combined antipyschotic prescription for inpatients: A retrospective study
Böke Ö.; Sarisoy G.; Akbaş S.; Aker S.; Korkmaz S.; Aker A.A.; Şahin A.R. (2006)Objective: The developments experienced in the treatment of schizophrenia has increased the number of antiphyschotic drugs and thus treatment options of the clinicians accordingly, but this increaseas caused difficulties ... -
Demographic and clinical characteristi cs in schizophrenia: A multi center cross-sectional case record study
Objective: The aim of the present study is to assess the relationship between demographic characteristics and suicide attempts, physically aggressive behavior, substance abuse, repeated hospitalizations, and continuous ... -
Early maladaptive schemas in patients with bipolar and unipolar disorder
Özdin S.; Sarisoy G.; Şahin A.R.; Arik A.C.; Özyıldız Güz H.; Böke Ö.; Karabekiroğlu A. (Taylor and Francis Ltd, 2018)Objective: The aim of our study is to determine the difference between the bipolar disorder, unipolar disorder and control groups in terms of maladaptive schemes and childhood trauma. Methods: Two groups of patients under ... -
Evaluation of psychiatric disorders among admittances to 112 emergency services in Samsun - 2004
Objective: This study aimed to determine the demographic and clinical characteristics of the patients admitted to 112 emergency services with psychiatric disorders in Samsun city centre in 2004. Methods: Data were obtained ... -
Multiple antipsychotics use in patients with schizophrenia: Why do we use it, what are the results from patient follow-ups?
Civan Kahve A.; Kaya H.; Gül Çakıl A.; Ünverdi Bıçakçı E.; Göksel P.; Göka E.; Böke Ö. (Elsevier B.V., 2020)In this study, the rates of antipsychotic polypharmacy, factors affecting combined drug use, the relationship between antipsychotic polypharmacy as it relates to duration of hospitalization and re-hospitalization, and ...
